The Rare Journey Needs a Special Pharmacy Partner

Today’s guest post is from Bansi Nagji, Chief Executive Officer at PANTHERx Rare. Bansi argues that rare disease pharmacy is a fundamentally different model built around precision, speed, and hyper-personalized care. He suggests how manufacturers and stakeholders must rethink their assumptions to effectively support the unique demands of rare disease patient journeys. Hear from PANTHERx patients and their caregivers about what it’s like to live each day with a rare disease. Read on for Bansi’s insights. Read more » © 2006-2026 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved. This Feed is for…

Today’s guest post is from Bansi Nagji, Chief Executive Officer at PANTHERx Rare.

Bansi argues that rare disease pharmacy is a fundamentally different model built around precision, speed, and hyper-personalized care. He suggests how manufacturers and stakeholders must rethink their assumptions to effectively support the unique demands of rare disease patient journeys.

Hear from PANTHERx patients and their caregivers about what it’s like to live each day with a rare disease.

Read on for Bansi’s insights.
Read more »

© 2006-2026 HMP Omnimedia, LLC d/b/a Drug Channels Institute, an HMP Global Company. All rights reserved. This Feed is for personal non-commercial use only.

       

Source: Drug Channels